An investigation for shareholders in Horizon Pharma PLC (NASDAQ:HZNP) shares over potential wrongdoing at Horizon Pharma PLC was announced and NASDAQ:HZNP stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWire) -- 11/16/2015 --An investigation for shareholders in NASDAQ:HZNP shares was announced over potential breaches of fiduciary duties by certain directors at Horizon Pharma.

Investors who purchased shares of Horizon Pharma PLC (NASDAQ:HZNP) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Horizon Pharma officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

On October 19, 2015, an article entitled "Drug Makers Sidestep Barriers on Pricing" was published noting that certain drug manufacturers, including Horizon Pharma PLC, have begun using specialty pharmacies "to circumvent efforts of insurers and pharmacists to switch patients to generic components, or even to the over-the-counter versions." According to the article, Horizon Pharma PLC urges doctors to submit prescriptions to a mail-order specialty pharmacy affiliated with the drug company, rather than sending patients directly to the drugstore. The article further represents that Horizon Pharma PLC's use of specialty pharmacies allows Horizon Pharma PLC to charge inflated prices for prescriptions.

Shares of Horizon Pharma PLC (NASDAQ:HZNP) closed on November 13, 2015, at $17.9 per share.

Those who purchased shares of Horizon Pharma PLC (NASDAQ:HZNP) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com